Based on the increased 2HG levels in the IDH1R132H-mutant tumors as well as the transcriptomic data, we wanted to examine if H3K27me3 levels differed between IDH1 mutant and wild-type mouse glioma cells. This evidence concerns the gene IDH1 and central nervous system cancer.